N. Soroka

Efficacy and safety of netakimab, anti-IL-17A monoclonal antibody, in patients with ankylosing spondylitis. Results of phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA

Mazurov Vi, I. Z. Gaydukova, N. Soroka et al. · Rheumatology Science and Practice · 2020 · 17 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +15

Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA

Mazurov Vi, I. Z. Gaydukova, N. Soroka et al. · Modern Rheumatology Journal · 2020 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: Results of phase II AURORA study

Mazurov Vi, E. G. Zotkin, I. Z. Gaydukova et al. · Rheumatology Science and Practice · 2021 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Effectiveness and safety of BCD180, anti-TRBV9<sup>+</sup> T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTA

Mazurov Vi, I. Z. Gaydukova, S. Lapshina et al. · Rheumatology Science and Practice · 2024 · 16 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Effectiveness and safety of levilimab in combination with methotrexate in treatment of patients with active rheumatoid arthritis resistant to methotrexate monotherapy (double-blinded randomized placebo controlled phase III clinical study SOLAR)

Mazurov Vi, A. M. Prystrom, N. Soroka et al. · Modern Rheumatology Journal · 2021 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17